Vitamin d deficiency in cystic fibrosis
- PMID: 20148079
- PMCID: PMC2817861
- DOI: 10.1155/2010/218691
Vitamin d deficiency in cystic fibrosis
Abstract
Cystic Fibrosis is the most common inherited genetic respiratory disorder in the Western World. Hypovitaminosis D is almost universal in CF patients, likely due to a combination of inadequate absorption, impaired metabolism, and lack of sun exposure. Inadequate levels are associated with the high prevalence of bone disease or osteoporosis in CF patients, which is associated with increased morbidity including fractures, kyphosis, and worsening pulmonary status. Treatment goals include regular monitoring 25 hydroxyvitamin D (25OHD) levels with aggressive treatment for those with levels <75 nmol/L (<30 ng/mL). More research is needed to determine optimal supplementation goals and strategies.
Figures
References
-
- Cystic Fibrosis Foundation. Patient Registry 2004 Annual Report. Bethesda, Md, USA: Cystic Fibrosis Foundation; 2005.
-
- O’Sullivan BP, Flume P. The clinical approach to lung disease in patients with cystic fibrosis. Seminars in Respiratory and Critical Care Medicine. 2009;30(5):505–513. - PubMed
-
- CFTR Mutation Database. http://www.genet.sickkids.on.ca/cftr/app.
-
- Cystic Fibrosis Foundation. Frequently asked questions. April 2009, http://www.cff.org/AboutCF/Faqs.
-
- Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. Journal of the American Dietetic Association. 2001;101(4):438–442. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources